Harm J Gijsman
- Mania after transcranial magnetic stimulation in PTSDHarm J Gijsman
Am J Psychiatry 162:398; author reply 398-400. 2005
- Antidepressants for bipolar depression: a systematic review of randomized, controlled trialsHarm J Gijsman
Department of Psychiatry, Warneford Hospital, Oxford, UK
Am J Psychiatry 161:1537-47. 2004..This study reviewed the evidence from randomized, controlled trials on the efficacy and safety of antidepressants in the short-term treatment of bipolar depression...
- Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patientsAnn L Sharpley
University Department of Psychiatry, Warneford Hospital, Oxford, Oxfordshire, UK
J Clin Psychiatry 64:192-6. 2003..This study aimed to assess whether risperidone produced typical antidepressant-like effects in the polysomnogram of healthy subjects and in depressed patients unresponsive to antidepressant medication...
- A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine functionHarm J Gijsman
University of Oxford, Department of Psychiatry, Warneford Hospital, Oxford OX3 7JX, UK
Psychopharmacology (Berl) 160:192-7. 2002..The amino acid mixture we tested previously is unpalatable, whereas mixtures containing only branch chain amino acids can be made more palatable. However, the effects of such mixtures on dopamine function in humans have not been studied...
- Effect of branch chain amino acids supplemented with tryptophan on tyrosine availability and plasma prolactinAntonina Scarna
Psychopharmacology (Berl) 159:222-3. 2002
- Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteersHarm J Gijsman
Centre for Human Drug Research, Department of Clinical Pharmacology, Leiden University, Leiden, The Netherlands
J Clin Psychopharmacol 22:183-9. 2002..Further increase of the dose of 5-HTP might improve the size of the effect on endpoints as long as the tolerability remains good...
- Saccadic peak velocity and EEG as end-points for a serotonergic challenge testHarm J Gijsman
Centre for Human Drug Research, Leiden, The Netherlands
Hum Psychopharmacol 17:83-9. 2002..We previously reported that a single dose of the serotonin receptor agonist meta-chlorophenylpiperazine increased the peak velocity of saccadic eye movements and decreased low-frequency electroencephalographic activity...